NIH | National Cancer Institute | NCI Wiki  

Error rendering macro 'rw-search'

null

Versions Compared

Old Version 14

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

compared with

New Version 15

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Revised to be consistent.

...

Data ElementDescription
NCI IDIdentifier assigned to this trial by the CTRP.

Include Page
Trial Attribute NCI ID - Include v4.4
Trial Attribute NCI ID - Include v4.4

DCP IDIdentifier assigned to this trial by the DCP (Division of Cancer Prevention). For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers.
CTEP IDIdentifier assigned to this trial by the CTEP (Cancer Therapy Evaluation Program). For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers.
Lead Organization

Include Page
Trial Attribute Lead Org Name - Include v4.4

Name of the principal administrative organization responsible for this trial's research protocol.

Trial Attribute Lead Org Name - Include v4.4
For more information, refer to Abstracting Sponsors and Responsible Parties.

Sponsor

Include Page
Trial Attribute Sponsor

Name of the primary organization that oversees implementation of study and is responsible for data analysis.

- Include v4.4
Trial Attribute Sponsor - Include v4.4
 For more information, refer to Abstracting Sponsors and Responsible Parties.

Send trial information to Clinical 

Value indicating whether the system sends the trial information to ClinicalTrials.gov in the automated nightly batch updates (via FTP):

  • Yes. The system sends the trial information.
  • No. The system does not send the trial information.
  • N/A. The trial does not satisfy other criteria.

For more information, refer to Abstracting NCI-Specific Information.

Completion Date

Date on which final data was collected for the trial, or the date on which that is expected to happen. For more information, refer to Abstracting Trial Statuses.

Processing Status

Include Page
Trial Attribute Current Trial Processing Status

Value indicating the current processing status of the trial. 

- Include v4.4
Trial Attribute Current Trial Processing Status - Include v4.4
 For

For

more information, refer to Abstracting Trial Statuses

and Trial Processing Statuses in the CTRP

.

Current trial status

Include Page

Current stage or state of a clinical trial or study relative to other stages and its ability to enroll participants/patients. 

Trial Attribute Current Trial Status - Include v4.4
Trial Attribute Current Trial Status - Include v4.4
 For

For

more information, refer to Abstracting Trial Statuses

and Trial Status Values in the CTRP and ClinicalTrials.gov

.

Primary Completion DateDate on which the final subject was examined or received an intervention, or the date on which that is expected to happen.

Include Page
Trial Attribute Primary Completion Date - Include v4.4
Trial Attribute Primary Completion Date - Include v4.4
 

For more information, refer to Abstracting Trial Statuses.

Primary Completion TypeValue indicating whether the completion date is the one on which the trial is expected to complete (Anticipated), or the date on which it actually completed (Actual). For more information, refer to Abstracting Trial Statuses.
Section 801 IndicatorValue indicating whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801. For more information, refer to Abstracting Regulatory Information.
Processing CommentsAny comments that an abstractor has recorded for this trial, on the Trial Identification page or Dashboard Details page. For more information, refer to Tracking and Managing Trial Records.
CTRO Override Flag CommentsAny comments that an abstractor has recorded (with the "Send Trial Information to ClinicalTrials.gov?" value) for this trial. For more information, refer to Abstracting NCI-Specific Information.

...